Biomaterials-associated thrombosis is dependent critically upon electrochemical response of fibrinogen on material surface. The relationship between the response and anti-thrombogenicity of biomaterials is not well-established. Titanium oxide appears to have good anti-thrombogenicity and little is known about its underlying essential chemistry. We correlate their anti-thrombogenicity directly to electrochemical behaviors in fibrinogen containing buffer solution. High degree of inherent n-type doping was noted to contribute the impedance preventing charge transfer from fibrinogen into film (namely its activation) and consequently reduced degree of anti-thrombogenicity. The impedance was the result of high donor carrier density as well as negative flat band potential.
WilliamsDF. On the mechanisms of biocompatibility. Biomaterials2008; 29: 2941–2953.
2.
RatnerBD. The catastrophe revisited: blood compatibility in the 21st century. Biomaterials2007; 28: 5144–5147.
3.
GorbetMBSeftonMV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials2004; 25: 5681–5703.
4.
VoglerEASledleckiCA. Contact activation of blood-plasma coagulation. Biomaterials2009; 30: 1857–1869.
5.
O’BrienBCarrollW. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater2009; 5: 945–958.
6.
BakirM. Haemocompatibility of titanium and its alloys. J Biomater Appl2012; 27: 3–15.
7.
HuangNYangPLengYX. Hemocompatibility of titaniumoxide films. Biomaterials2003; 24: 2177–2187.
MaitzMFPhamMTWieserE. Blood compatibility of titanium oxide with various crystal structure and element doping. J Biomater Appl2003; 17: 303–319.
10.
LiuXHZhengZHZhouZY. Surface modification of titanium based biomaterials by ion beam. J Biomater Appl1996; 10: 330–337.
11.
ZhangFLiuXHMaoYJ. Artificial heart valves: improved hemocompatibility by titanium oxide coatings prepared by ion beam assisted deposition. Surf Coat Technol1998; 103-104: 146–150.
12.
LiuJXYangDZShiF. Sol–gel deposited TiO2 film on NiTi surgical alloy for biocompatibility improvement. Thin Solid Films2003; 429: 225–230.
13.
ChuCLWangRMHuT. XPS and biocompatibility studies of titania film on anodized NiTi shape memory alloy. J Mater Sci Mater Med2009; 20: 223–228.
14.
WangXHYuLJLiCR. Competitive adsorption behavior of human serum albumin and fibrinogen on titanium oxide films coated on LTI-carbon by IBED. Colloid Surf B: Biointerfaces2003; 30: 111–121.
15.
SawyerPN. Significance of electrochemical phenomena in intravascular thrombosis. Nature1965; 206: 1162–1163.
16.
SawyerPNSrinivasanSChopraPS. Electrochemistry of thrombosis - an aid in the selection of prosthetic materials. J Biomed Mater Res1970; 4: 43–55.
17.
BaurschmidtPSchaldacM. The electrochemical aspects of the thrombogenicity of a material. J Bioeng1977; 1: 261–278.
18.
BolzAAmonMOzbekC. Coating of cardiovascular stents with a semiconductor to improve their hemocompatibility. Tex Heart Inst J1996; 23: 162–166.
19.
ShihCCShihCMSuYY. The interaction of selected semiconducting biomaterials with platelet-rich plasma and whole blood. J Biomed Mater Res Part A2005; 74A: 325–337.
20.
GettensRTTGilbertJL. Fibrinogen adsorption onto 316 L stainless steel under polarized conditions. J Biomed Mater Res Part A2008; 85: 176–187.
21.
ShihCCShihCMSuYY. Quantitative evaluation of thrombosis by electrochemical methodology. Thromb Res2003; 111: 103–109.
22.
KellyPJArnellRD. Magnetron sputtering: a review of recent developments and applications. Vacuum2000; 56: 159–172.
23.
BottAW. Electrochemistry of semiconductors. Curr Separat1998; 17: 87–91.
24.
WangerCDRiggsWMDavisLE. Handbook of X-ray photoelectron spectroscopy, 1st ed. Eden Prairie, MN: Perkin–Elmer, pp. 68–70.
25.
DieboldU. Structure and properties of TiO2 surfaces: a brief review. Appl Phys A2003; 76: 681–687.
26.
ClarkeMLWangJChenZ. Conformational changes of fibrinogen after adsorption. J Phys Chem B2005; 109: 22027–22035.
27.
GibbinsJM. Platelet adhesion signaling and the regulation of thrombus formation. J Cell Sci2004; 117: 3415–3425.
28.
PackhamMA. The behaviour of platelets at foreign surfaces. Proc Soc Exp Biol Med1988; 189: 261–274.
29.
VromanL. What factors determine thrombogenicity. Bull N Y Acad Med1972; 48: 302–310.
30.
Guha ThakurtaSMillerRSubramanianA. Investigation of platelet responses and clotting characteristics of in situ albumin binding surfaces. J Biomater Appl2012; 26: 529–547.
31.
SawyerPNSrinivasanS. Relation between thrombosis on metal electrodes and the position of metal in the electromotive series. Nature1967; 215: 1494–1494.
32.
HongJAzensAEkdahlKN. Material-specific thrombin generation following contact between metal surfaces and whole blood. Biomaterials2005; 26: 1397–1403.
33.
MorrisonSR. Electrochemistry at semiconductor and oxidized metal electrodes, 1st ed. New York: Plenum Press, pp. 59–75.
34.
BothaSJ. Surface properties and bio-acceptability of Ti2O3 surfaces. Mater Sci Eng A1998; 243: 221–230.
35.
ShihCCShihCMSuYY. Characterization of the thrombogenic potential of surface oxides on stainless steel for implant purposes. Appl Surf Sci2003; 219: 347–362.
36.
ManiGFeldmanMDPatelD. Coronary stents: a materials perspective. Biomaterials2007; 28: 1689–1710.
37.
HuWJEatonJWUgarovaTP. Molecular basis of biomaterial-mediated foreign body reactions. Blood2001; 98: 1231–1238.
38.
JayabalanM. Biological interactions: causes for risks and failures of biomaterials and devices. J Biomater Appl1993; 8: 64–71.
39.
CourtneyJMLambaNMKSundaramS. Biomaterials for blood-contacting applications. Biomaterials1994; 15: 737–744.
40.
RatnerBDHoffmanASSchoenFJ. Biomaterials science: an introduction to materials in medicine, 2nd ed. San Diego: Academic Press, pp. 367–378.
